Cipla is setting up a Rs.85.5 crore bulk drugs
plant at Bangalore. The Karnataka government has formally cleared the proposal
for the plant on 9 September 2004. The plant would come up on a 30 acres of land
in Phase 5 of Bommasandra Industrial Area. This plant would be the second southern
plant of the company after Goa.
Cipla proposes to make a range of bulks such as
cisplatin, carboplatin, etoposide used in the treatment of cancer, amlodipine
and felodipine for cardiac problems and quiniline antibiotics such as
levofloxacin and mitoxantrone HCI.